Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

NeuroPace (NPCE) Shares Issued (2020 - 2026)

NeuroPace has reported Shares Issued over the past 7 years, most recently at $10000.0 for Q1 2026.

For Q1 2026, Shares Issued fell 97.4% year-over-year to $10000.0; the TTM value through Mar 2026 reached $1.5 million, down 67.11%, while the annual FY2025 figure was $1.9 million, 2.9% down from the prior year.
Shares Issued for Q1 2026 was $10000.0 at NeuroPace, down from $723000.0 in the prior quarter.
Over five years, Shares Issued peaked at $3.0 million in Q3 2024 and troughed at $1000.0 in Q1 2022.
A 5-year average of $530062.5 and a median of $467000.0 in 2023 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: skyrocketed 72000.0% in 2024 and later tumbled 99.97% in 2025.
Year by year, Shares Issued stood at $213000.0 in 2022, then surged by 157.75% to $549000.0 in 2023, then increased by 8.38% to $595000.0 in 2024, then grew by 21.51% to $723000.0 in 2025, then tumbled by 98.62% to $10000.0 in 2026.
Business Quant data shows Shares Issued for NPCE at $10000.0 in Q1 2026, $723000.0 in Q4 2025, and $1000.0 in Q3 2025.